Clinical Trials Landscape in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Trials Landscape in Brazil

Clinical Trials Landscape in Brazil – Top CRO Companies

Clinical trials are essential for advancing medical research and improving healthcare outcomes. In recent years, Brazil has emerged as a prominent player in the global clinical trials landscape, offering a fertile ground for groundbreaking research.

This blog post explores the clinical trials landscape in Brazil, highlighting its strengths, regulatory framework, research infrastructure, and recent developments. By understanding Brazil’s unique advantages and opportunities, we can gain insights into its contributions to medical research and the potential it holds for future advancements.

Overview of Brazil’s Clinical Trials Landscape

Brazil boasts a robust and dynamic clinical trials landscape, attracting both domestic and international researchers. With its vast and diverse population, Brazil offers a rich pool of potential participants across various therapeutic areas.

The country’s extensive healthcare network, encompassing public and private institutions, facilitates the recruitment of patients, ensuring sufficient sample sizes for meaningful clinical research. Additionally, Brazil’s vibrant research community, consisting of renowned academic institutions and hospitals, contributes to its status as a preferred destination for clinical trials.

Regulatory Framework and Ethical Considerations

Brazil has a well-established regulatory framework for clinical trials overseen by the National Health Surveillance Agency (ANVISA). ANVISA ensures that trials adhere to rigorous ethical and scientific standards, safeguarding participant rights and ensuring data integrity.

Ethical considerations are paramount, with Institutional Review Boards (IRBs) playing a crucial role in the approval process.

These safeguards ensure that trials are conducted ethically and in compliance with Good Clinical Practice (GCP) guidelines.

Advantages of Conducting Clinical Trials in Brazil

Brazil offers numerous advantages that make it an attractive destination for clinical research. Firstly, its diverse population, encompassing different ethnicities and genetic backgrounds, enhances the generalizability of research findings. This diversity allows researchers to assess the efficacy and safety of treatments in various patient populations.

Furthermore, Brazil’s large population size and well-established healthcare system enable efficient patient recruitment, reducing trial timelines and costs.

Brazil’s extensive research infrastructure is another notable advantage. The country is home to leading research institutions and hospitals equipped with state-of-the-art facilities, fostering collaborations and facilitating high-quality clinical trials.

The presence of experienced research professionals ensures the successful execution of trials and reliable data collection.

Clinical Trials Landscape in Brazil 

Clinical Trials Landscape in Brazil

Research Collaboration and Funding Opportunities

Brazil actively promotes research collaboration and fosters partnerships with international organizations. The country’s participation in multinational trials and its engagement with global research networks enhance knowledge exchange and facilitate access to cutting-edge treatments and therapies.

Moreover, Brazil provides attractive funding opportunities for clinical research through governmental agencies, such as the National Council for Scientific and Technological Development (CNPq) and various research funding foundations. These initiatives stimulate research activities and support the growth of clinical trials in Brazil.

Recent Developments and Future Outlook

Brazil’s commitment to advancing clinical research is evident in recent developments. The government has implemented initiatives to streamline regulatory processes, reducing approval timelines and enhancing transparency. Efforts to improve data management systems and promote the use of electronic health records have facilitated efficient trial conduct and data collection.

Looking ahead, Brazil’s clinical trials landscape holds immense promise. The country’s strategic investments in research infrastructure, the promotion of research collaboration, and the emphasis on public-private partnerships create a favorable environment for medical innovation.

Brazil’s research community continues to evolve, attracting international sponsors and forging alliances with global institutions, which contributes to the country’s role in shaping the future of clinical trials.


Brazil’s clinical trials landscape represents a dynamic and promising ecosystem for medical research. With its diverse population, robust regulatory framework, well-established research infrastructure, and a collaborative approach to research, Brazil is poised to continue making significant contributions to the advancement of clinical trials.

By capitalizing on its strengths and addressing any challenges, Brazil has the potential to drive medical innovation, improve patient care, and enhance global healthcare outcomes.

Clinical Trials Landscape in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trials Landscape in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trials Landscape in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trials Landscape in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trials Landscape in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trials Landscape in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trials Landscape in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trials Landscape in Brazil

The Cohortias Team

Clinical Trials Landscape in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trials Landscape in Brazil

Network & Partnerships